Global Weekly Picks

Community Contributor

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

$RKLB Investment Thesis: early mover in a fast growing industry. Likely to experience share price volatility as they scale $RKLB is a top play for exposure to a vertically integrated space company; a lot rides on the success of the Neutron rocket The Bull Case: Neutron Unlocks Scale The current Electron rocket gives $RKLB a reliable, high-cadence launch with a track record (74+ flights) and market credibility.

View narrative

US$16.25

268.7% overvalued

30.00%

Revenue growth p.a.

4.8k

Excellon Resources

Agricola

Community Contributor

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Excellon Resources Inc. is a Toronto-based mineral exploration and development company focused on silver and gold projects in Peru, the United States, and Germany.

View narrative

CA$31.8

98.5% undervalued

4.1k

Credit Corp Group

FundamentallySarcastic

Community Contributor

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08

Credit Corp Group Limited ASX: CCP Market Cap: AU$923.0m Weighted Average Number of Shares: 80.37m The Business CCP’s main business is acquiring portfolios of bad debts from financial institutions and collecting on them for profit. As the original lenders write off these debts, the portfolios are generally bought at a discount.

View narrative

AU$12.64

12.1% overvalued

7.00%

Revenue growth p.a.

609

Load previous narratives

National Atomic Company Kazatomprom JSC

Kazatomprom: An Undervalued Leader in a Resurgent Uranium Market

Joint Stock Company Kazatomprom (KAP) presents a compelling investment opportunity, positioned as the world's largest and lowest-cost producer of uranium. Our mid-case scenario projects a target price of 37,783.14 KZT by the end of 2029, representing a potential total return of 61.1% from the last close of 23,456.08 KZT.Read more

184

US$40.23

27.3% overvalued

TibiT's Fair Value

Revenue

10.49% p.a.

Profit Margin

29.8%

Future PE

10x

Price in 2030

US$61.75

Sleep Cycle

Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model

Update Q1 2025 (updated 250510) The latest user‐growth data suggest headwinds for top-line revenue, but management’s active repricing initiatives should help offset this. By combining modest user gains with targeted price increases, the company can still drive overall revenue growth.Read more

5.3k

SEK 38.04

32.6% undervalued

Mandelman's Fair Value

Revenue

3.15% p.a.

Profit Margin

21%

Future PE

15x

Price in 2028

SEK 44.84

Addus HomeCare

Quality at a Premium. A time to watch, not to buy?

Key Takeaways Consistent revenue growth, strong profitability, and a pristine balance sheet position Addus for sustained disciplined acquisitive growth and improved operational efficiency. The company's business model is resilient and defensive against cyclical downturns, making it a safe haven in times of economic uncertainty.Read more

3.6k

US$154.56

27.5% undervalued

DanielGC's Fair Value

Revenue

14.72% p.a.

Profit Margin

6.51%

Future PE

25.2x

Price in 2030

US$214.54

Redington

Redington set to ride the ongoing AI and Cloud boom by transforming to SaaS marketplace and vendor business model

1. Digital Transformation Driving IT Demand Rising IT spending in India, Middle East, and emerging markets.Read more

722

₹835.53

67.4% undervalued

abhishek1990's Fair Value

Revenue

20% p.a.

Profit Margin

Future PE

30x

Price in 2027

₹1.26k

IREN

IREN will achieve a 51% revenue surge in the next 5 years

Pour calculer la valeur intrinsèque d'IREN dans un scénario conservateur, on peut utiliser une méthode de valorisation telle que les flux de trésorerie actualisés (DCF). Voici un aperçu basé sur les données disponibles : Points clés : Prix actuel de l'action : 7,15 $US.Read more

293

US$11

225.5% overvalued

Dark_Oli's Fair Value

Revenue

35.83% p.a.

Profit Margin

13.24%

Future PE

28.17x

Price in 2029

US$16.04

National HealthCare

NHC Analysis: Quality at a Good Price. A Golden Opportunity?

Key Takeaways A highly diversified business model and a pristine balance sheet position National HealthCare Corporation for sustained, profitable growth. The company's current low valuation is a result of a short-term drop in net income, which we believe is temporary and creates a compelling investment opportunity.Read more

1.8k

US$179.8

21.2% undervalued

DanielGC's Fair Value

Revenue

18.8% p.a.

Profit Margin

7.19%

Future PE

15.9x

Price in 2030

US$249.51

Verve Group

Verve Group: A Tale of Three Futures

Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.Read more

2.1k

€4.02

57.0% undervalued

TibiT's Fair Value

Revenue

8.5% p.a.

Profit Margin

14.8%

Future PE

10x

Price in 2030

€5.43

Amazon.com

Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision

Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.Read more

4.4k

US$234.75

3.4% undervalued

Zwfis's Fair Value

Revenue

13.6% p.a.

Profit Margin

10.54%

Future PE

31.96x

Price in 2028

US$295.73

Opthea

OPTHEA - Write-off

--- [Narrative update per Investor announcement 24-Mar-2025] --- The analysis below was written ahead of Opthea’s Phase 3 results. As stated, the thesis was highly dependent on trial success.Read more

1.2k